bullish
Eubiologics IPO Part 1 - Schedule, Financials & Valuation
341 Views08 Jan 2017 02:20
Eubiologics is a very "young" vaccine company that develops an oral cholera vaccine product called "Euvichol". This company will be Korea's first...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
- EuBiologics (206650 KS): Cashing on Vaccine Business13 Oct 2021
- Eubiologics IPO Part 3 - IPO Bookbuilding Results & Personal View13 Jan 2017
- Eubiologics IPO Part 2 - Growth Potential & Appropriate Valuation Level10 Jan 2017
- Eubiologics IPO Part 1 - Schedule, Financials & Valuation08 Jan 2017
x